Market Overview:
The global perphenazine drug market is expected to grow at a CAGR of 3.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of psychiatric disorders, rising geriatric population, and growing demand for injectable perphenazine solutions. However, the high cost of treatment and lack of awareness about perphenazine drugs are some factors that are likely to restrain the growth of this market in certain regions. Based on type, the global perphenazine drug market can be segmented into oral forms and injectable solution. The oral forms segment is expected to account for a larger share of this market than the injectable solution segment during the forecast period. This can be attributed to factors such as ease-of-use and lower costs as compared with injectable solutions. Based on application, the global perphenazine drug market can be divided into psychosis and antiemetic applications.
Product Definition:
Perphenazine is a drug used to treat schizophrenia and other psychotic disorders. It belongs to a class of drugs called phenothiazines.
Oral Forms:
Oral forms are the solid or liquid medications that can be administered in the mouth. They help patients who cannot take pills, tablets or injections. The most common types of oral forms include tablets and capsules. Some oral drugs have a delayed-release formulation that is administered after a set period of time for better results.
Injectable Solution:
Injectable solution is a form of drug delivery system that allows drugs to be administered by the intravenous or subcutaneous route. The most common injectable solutions are sterile water-based solutions, however, there are other types as well such as oil-based and non-water based.
The advantages of injectable solution include easy drug administration with minimum side effects; it offers improved patient convenience in terms of dose accuracy.
Application Insights:
The antiemetic segment dominated the global perphenazine drug market in terms of revenue share in 2017. This is attributed to the high incidence of motion sickness and other emetogenic disorders, such as gastritis, nausea and vomiting among children. Moreover, increasing awareness about these drugs as an alternative to H1-blockers for treating acute migraine attacks is expected to boost demand over the forecast period.
Antiemetic drugs are used for various purposes including prevention from motion sickness or other emetogenic situations like gastroenteric illness or chemotherapy-induced nausea/vomiting. These are available as oral tablets and injections; however, perphenazine injection is more popular across all regions due to its ease of use compared to oral forms.
Regional Analysis:
North America dominated the global perphenazine drug market in 2017. The high prevalence of mental disorders and availability of effective treatment for them are some factors responsible for its largest share. Moreover, increasing awareness about available treatment options is also expected to drive the regional market over the forecast period. In addition, presence of key pharmaceutical companies such as Johnson & Johnson Services, Inc.; Pfizer Inc.; and Merck & Co., Inc.
Asia Pacific region is expected to witness lucrative growth over the coming years owing to growing patient pool suffering from anxiety disorder and psychotic disorders coupled with rising disposable income levels in emerging economies such as India and China.
Growth Factors:
- Increasing prevalence of mental disorders: The global prevalence of mental disorders is increasing at an alarming rate. This is primarily due to the changing lifestyle and stress levels. According to the World Health Organization (WHO), around 450 million people suffer from some form of mental disorder worldwide. This number is expected to increase to 615 million by 2030. This will create a large pool of patients who will require treatment, thereby driving the growth of the perphenazine drug market.
- Rising awareness about mental health: There is a growing awareness about mental health and its importance in overall well-being among people across all age groups, thanks to various campaigns by NGOs and healthcare organizations. As a result, more people are seeking treatment for their mental health issues, which is driving demand for perphenazine drugs globally.
Scope Of The Report
Report Attributes
Report Details
Report Title
Perphenazine Drug Market Research Report
By Type
Oral Forms, Injectable Solution
By Application
Psychosis, Antiemetic
By Companies
Teva, Sandoz, Endo, Mylan, ZHPHARMA, Shandong Boshan Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Perphenazine Drug Market Report Segments:
The global Perphenazine Drug market is segmented on the basis of:
Types
Oral Forms, Injectable Solution
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Psychosis, Antiemetic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Teva
- Sandoz
- Endo
- Mylan
- ZHPHARMA
- Shandong Boshan Pharma
Highlights of The Perphenazine Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral Forms
- Injectable Solution
- By Application:
- Psychosis
- Antiemetic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Perphenazine Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Perphenazine is a medication used to treat schizophrenia and bipolar disorder. It works by blocking the effects of dopamine, a chemical messenger in the brain.
Some of the key players operating in the perphenazine drug market are Teva, Sandoz, Endo, Mylan, ZHPHARMA, Shandong Boshan Pharma.
The perphenazine drug market is expected to register a CAGR of 3.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Perphenazine Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Perphenazine Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Perphenazine Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Perphenazine Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Perphenazine Drug Market Size & Forecast, 2020-2028
4.5.1 Perphenazine Drug Market Size and Y-o-Y Growth
4.5.2 Perphenazine Drug Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Oral Forms
5.2.2 Injectable Solution
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Psychosis
6.2.2 Antiemetic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Perphenazine Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Perphenazine Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Oral Forms
9.6.2 Injectable Solution
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Psychosis
9.10.2 Antiemetic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Oral Forms
10.6.2 Injectable Solution
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Psychosis
10.10.2 Antiemetic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Oral Forms
11.6.2 Injectable Solution
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Psychosis
11.10.2 Antiemetic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Oral Forms
12.6.2 Injectable Solution
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Psychosis
12.10.2 Antiemetic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Oral Forms
13.6.2 Injectable Solution
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Psychosis
13.10.2 Antiemetic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Perphenazine Drug Market: Competitive Dashboard
14.2 Global Perphenazine Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Teva
14.3.2 Sandoz
14.3.3 Endo
14.3.4 Mylan
14.3.5 ZHPHARMA
14.3.6 Shandong Boshan Pharma
